BOLD vs CE
Boundless Bio, Inc. Common Stock (BOLD) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Celanese Corporation (CE) is a chemicals company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. CE currently screens at market cap $5.92B.
Not investment advice. Open the BOLD and CE stock pages for the full models.
Not investment advice.